Tao Synergies Inc. Files Form 10-K/A Amendment: Key Audit Correction and Critical Valuation Matters
Tao Synergies Inc. (Nasdaq: TAOX), a publicly traded company on the Nasdaq Stock Market, has filed an Amendment No. 1 to its Annual Report on Form 10-K for the fiscal year ended December 31, 2025. This amendment is particularly significant for shareholders and investors, as it addresses a correction to the auditor’s report—specifically the description of a critical audit matter related to the valuation of the company’s preferred stock embedded derivative liabilities.
Key Points from the Amendment
- Correction in Audit Report: The company’s independent registered public accounting firm, Stephano Slack LLC (PCAOB ID#03523), has revised its report to more accurately describe the critical audit matter concerning the valuation of preferred stock embedded derivative liabilities. The financial statements and auditor’s unqualified opinion remain unchanged, and the correction is consistent with Note 6 to the consolidated financial statements.
- Valuation of Preferred Stock and Embedded Derivative Liabilities: In 2025, Tao Synergies issued Series D and Series E Convertible Preferred Stock with complex embedded features. These features were determined to be bifurcated embedded derivatives, requiring fair value measurement at inception and each reporting date. The valuation process involved significant management judgment and specialized audit procedures, including discounted cash flow and “with-and-without” methodologies.
- Significant Valuation Results: The derivative liability associated with Series D Preferred Stock was valued at \$113,000 at inception and remeasured to \$2,000 as of December 31, 2025. The Series E Preferred Stock, issued on October 13, 2025, also featured similar debt-like characteristics and was accounted for as an embedded derivative liability.
- Audit Committee and Specialized Audit Effort: The critical audit matter required extensive auditor judgment and the involvement of fair value specialists to evaluate the models, assumptions (including common stock price, expected volatility, market discount rates, risk-free rates, dividend rates, redemption premiums, and expected terms), and consistency across reporting periods.
- Market Value and Shares Outstanding: As of June 30, 2025, the aggregate market value of common stock held by non-affiliates was \$19,435,501, based on the Nasdaq closing price. As of March 30, 2026, the company had 7,471,931 shares of common stock outstanding.
- Filings and Certifications: The amendment includes new certifications from the principal executive officer and principal financial officer, as well as auditor consent and updated XBRL documents.
- Other Disclosures: Tao Synergies is classified as a non-accelerated filer and a smaller reporting company, but not an emerging growth company or a shell company. The company has filed all required reports and is subject to SEC reporting obligations.
Potentially Price-Sensitive Information for Shareholders
- Restatement of Audit Report: The correction to the auditor’s report regarding the critical audit matter does not affect the auditor’s unqualified opinion or the financial statements, but it clarifies the valuation process and risk assessment for complex financial instruments. Shareholders should note that the company’s use of sophisticated derivative valuation models—and the risk factors associated with them—could have implications for future fair value adjustments and related financial statement volatility.
- Derivative Liability Valuations: The significant decrease in the derivative liability for Series D Preferred Stock (from \$113,000 to \$2,000) as of year-end may reflect changing market conditions, management assumptions, or successful risk mitigation. This could be viewed positively from a balance sheet perspective but warrants continued attention from investors.
- No Impact on Financial Statements: The correction does not change the audited financials or overall reported results, but the company’s transparency and responsiveness to audit committee concerns may be viewed favorably by the market.
What Shareholders Should Watch
- Future Embedded Derivative Valuations: The company’s ongoing issuance of complex preferred stock instruments introduces valuation risk, and changes in derivative liability could impact reported earnings and equity in future periods.
- Audit Committee Oversight: The company’s audit committee and independent auditors are actively monitoring these matters, which may reduce risk but also increase scrutiny of valuation assumptions.
- SEC Filings Compliance: Tao Synergies remains in compliance with all SEC reporting requirements, maintains its listing on Nasdaq under the symbol TAOX, and continues to provide full transparency to investors.
Conclusion
The filing of Form 10-K/A Amendment by Tao Synergies Inc. is a noteworthy event for shareholders. While the correction is technical in nature and does not alter the company’s audited financials, the focus on preferred stock embedded derivative valuations highlights the complexity and risk inherent in the company’s capital structure. Investors should monitor future developments related to derivative liabilities and audit committee oversight, as these could affect financial results and share value.
Disclaimer: This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell securities. Investors should review all SEC filings and consult with their financial advisor before making investment decisions. The information is based on Tao Synergies Inc.’s Form 10-K/A amendment and related disclosures as of June 5, 2026.
